Enko running shoes promised a dramatic departure from conventional footwear. Instead of relying mainly on foam cushioning, they incorporated a conspicuous mechanical suspension system beneath the foot. Their springs and articulated soles attracted attention from runners, designers and technology enthusiasts. However, the anticipated footwear revolution never materialised. The clearest answer to what happened is financial: the French company entered judicial liquidation in September 2019. Its story illustrates the difference between developing an intriguing invention and establishing a sustainable running-shoe business.
An ambitious mechanical alternative
Enko was developed by French engineer and runner Christian Freschi, who reportedly spent approximately twelve years refining the concept before its emergence in international coverage in 2015. An Indiegogo campaign helped introduce the shoes to potential customers. Their appeal was immediately understandable: if suspension protected cyclists from uneven surfaces, perhaps a comparable mechanism could make running more comfortable. Rather than resembling ordinary trainers, Enko shoes looked like compact machines attached to the feet.
The design used springs and a moving sole structure to compress under loading and rebound as the runner progressed through each step. Spring options were matched to the user’s body weight. The later G4 model offered seven cushioning categories covering runners weighing approximately 45–115 kilograms. A lever selected walking or running modes, while replaceable outsole studs were intended to extend service life. Enko promoted substantial shock absorption and durability, including a claimed lifespan of around 2,000 kilometres.
These features were genuinely distinctive, but the promotional language required caution. A spring can store and return mechanical energy; it cannot create energy. Furthermore, visible rebound does not establish that a shoe reduces the metabolic cost of running. Any benefit depends on the timing and direction of energy return, shoe weight, stability and the runner’s response. Similarly, reducing an impact measurement does not automatically demonstrate fewer injuries. Running injuries reflect interacting factors, including training load, tissue capacity and previous injury. Establishing clinical advantages would have required comparative studies following runners over time, rather than relying on demonstrations, testimonials or laboratory measurements of the suspension mechanism considered separately from its wearer.
Promise met practical compromises
Enko was more than a prototype that disappeared before reaching consumers. A July 2018 review in Canadian Running described running in the G4 and reported a noticeable spring-assisted sensation, a comfortable upper and a smooth transition towards the forefoot. The reviewer considered it potentially useful for longer, easier runs. These observations help explain why the shoes developed an interested audience: some runners genuinely enjoyed their unusual cushioning rather than merely admiring the engineering.
Nevertheless, the same review revealed significant compromises. The tested women’s size 8.5 weighed about 380 grams, substantial for performance running footwear. The reviewer also felt that the spring’s reloading limited rapid stride turnover and did not recommend the shoes for speed training. Walking initially felt awkward, and temporary calf tightness occurred during adaptation. Such observations are individual experiences, not controlled evidence, but they demonstrate that the suspension changed more than underfoot softness. It also changed the practical running experience.
Price presented another obstacle. The G4 retailed for approximately C$492 in that review, making it an expensive experiment for runners accustomed to conventional shoes. Promised durability could theoretically offset the purchase price, but buyers also needed confidence in replacement parts, warranties and continuing support. A shoe with specialised moving components creates different ownership expectations from a straightforward foam-soled trainer. These characteristics plausibly constrained its appeal, although the available records do not establish their individual contributions to the company’s failure.
The documented end of the business
The company’s disappearance is not simply an inference from an inactive website. French corporate records reproduced by Pappers identify ENKO, company number 799369855, as entering judicial liquidation on 11 September 2019. The court fixed its cessation-of-payments date at 9 August 2019, and the record states that activity ceased completely. On 1 March 2023, the liquidation was closed for insufficient assets. The company was removed from the commercial register on 2 March 2023. These dates distinguish the operational collapse from its later administrative conclusion.
What those records do not provide is a detailed commercial post-mortem. It would therefore be misleading to claim confidently that Enko failed because the shoes were ineffective, because runners rejected springs, or because a sporting authority banned the business. Financial insolvency is documented; the precise combination of sales, production costs, financing and operational difficulties is not established by the sources reviewed. Equally, enthusiastic product coverage should not be mistaken for independent proof of injury prevention or superior running economy.
Ultimately, Enko’s fate was the closure of an ambitious footwear venture, not a definitive scientific rejection of mechanical cushioning. Its shoes offered a striking alternative but combined novelty with weight, expense and unfamiliar mechanics. Their lasting lesson is that successful running footwear must deliver more than an impressive rebound: it needs convincing benefits, everyday usability, dependable support and a business capable of surviving beyond the initial excitement.